S

Samil Pharmaceutical Co Ltd
KRX:000520

Watchlist Manager
Samil Pharmaceutical Co Ltd
KRX:000520
Watchlist
Price: 10 350 KRW -0.19% Market Closed
Market Cap: 224.5B KRW

Gross Margin
Samil Pharmaceutical Co Ltd

36.5%
Current
37%
Average
48.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
36.5%
=
Gross Profit
79.2B
/
Revenue
217.2B

Gross Margin Across Competitors

No Stocks Found

Samil Pharmaceutical Co Ltd
Glance View

Market Cap
219.7B KRW
Industry
Pharmaceuticals

SAMIL PHARMACEUTICAL Co., Ltd. engages in the development and manufacture of pharmaceutical products. The company is headquartered in Seoul, Seoul. The Company’s products portfolio consists of gastro-intestinal drugs such as antiulcerants, gastroprokinetic agents, digestive enzymes with nutrients and laxatives under the brand names of Plybutine, Gliptide and others; antipyretic, analgesic and anti-inflammatory agents under the brand name Brufen; nutritional supplements such as vitamins, minerals and immunosuppressants, and others including antigout agents, anti-parkinsonism agents and others. In addition, it is engaged in the provision of miscellaneous goods. The firm distributes its products within domestic market and to overseas markets. On November 29, 2013, it transferred its entire shares of a Korea-based company, which is engaged in the sale of medical products.

Intrinsic Value
9 339.45 KRW
Overvaluation 10%
Intrinsic Value
Price
S
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
36.5%
=
Gross Profit
79.2B
/
Revenue
217.2B
What is the Gross Margin of Samil Pharmaceutical Co Ltd?

Based on Samil Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 36.5%.

Back to Top